AI Engines For more Details: Perplexity Kagi Labs You
Heart health: Rice bran contains antioxidants, including tocotrienols, tocopherols, and gamma-oryzanol, which have been shown to support heart health by reducing LDL cholesterol levels and preventing the oxidation of LDL cholesterol. Lowering LDL cholesterol levels can reduce the risk of cardiovascular diseases such as heart attacks and strokes.
Digestive health: Rice bran is a good source of dietary fiber, including both soluble and insoluble fibers. These fibers promote digestive health by preventing constipation, improving bowel movements, and supporting a healthy gut microbiota. Adequate fiber intake has also been associated with a reduced risk of colorectal cancer.
Blood sugar control: The fiber content in rice bran helps slow down the absorption of sugar into the bloodstream, which can help regulate blood sugar levels. This property makes rice bran a beneficial addition to the diet for individuals with diabetes or those at risk of developing diabetes.
Weight management: The high fiber content of rice bran can promote satiety and reduce overall calorie intake, making it potentially beneficial for weight management. Including rice bran in meals may help individuals feel fuller for longer periods, leading to reduced snacking and overeating.
Antioxidant activity: Rice bran contains various antioxidants, including vitamin E, ferulic acid, and oryzanol, which help neutralize harmful free radicals in the body. Free radicals are implicated in aging and various diseases, so consuming foods rich in antioxidants, such as rice bran, may help protect against oxidative damage.
Skin health: Some studies suggest that rice bran extract or oil applied topically may have benefits for skin health. It may help improve skin hydration, reduce inflammation, and protect against UV damage, potentially benefiting conditions such as dry skin, eczema, and premature aging.
Anti-inflammatory properties: Components of rice bran, such as gamma-oryzanol and tocotrienols, have shown anti-inflammatory properties in studies. These compounds may help reduce inflammation in the body, which is linked to various chronic diseases, including arthritis, diabetes, and cardiovascular diseases.
Cancer prevention: Some research suggests that compounds found in rice bran, such as ferulic acid and phytic acid, may have anticancer properties. These compounds may help inhibit the growth of cancer cells and reduce the risk of certain types of cancer, although more research is needed to confirm these effects.
Rank | Probiotic | Impact |
---|---|---|
species | Bifidobacterium adolescentis | Increases |
species | Bifidobacterium bifidum | Increases |
species | Bifidobacterium breve | Increases |
species | Bifidobacterium catenulatum | Increases |
species | Bifidobacterium longum | Increases |
species | Bifidobacterium pseudocatenulatum | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 0.6 | 0.6 | |
ADHD | 0.6 | 3.8 | -5.33 |
Age-Related Macular Degeneration and Glaucoma | 0.2 | 0.4 | -1 |
Allergic Rhinitis (Hay Fever) | 1.8 | 1 | 0.8 |
Allergies | 2.1 | 1.9 | 0.11 |
Allergy to milk products | 1.1 | 1.1 | 0 |
Alopecia (Hair Loss) | 0.8 | -0.8 | |
Alzheimer's disease | 3.9 | 3.3 | 0.18 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.9 | 1.5 | 0.27 |
Ankylosing spondylitis | 1.9 | 3.9 | -1.05 |
Anorexia Nervosa | 1.1 | 1.2 | -0.09 |
Antiphospholipid syndrome (APS) | 0.2 | -0.2 | |
Asthma | 1.3 | 1.4 | -0.08 |
Atherosclerosis | 1.6 | -1.6 | |
Atrial fibrillation | 2.3 | 4.3 | -0.87 |
Autism | 6.3 | 6.6 | -0.05 |
Barrett esophagus cancer | 0.9 | 0.6 | 0.5 |
benign prostatic hyperplasia | 0.3 | -0.3 | |
Bipolar Disorder | 1.4 | 2.1 | -0.5 |
Brain Trauma | 1.4 | 2 | -0.43 |
Breast Cancer | 0.6 | 0.6 | |
Carcinoma | 4 | 3.5 | 0.14 |
Celiac Disease | 4.8 | 2.4 | 1 |
Cerebral Palsy | 0.9 | 1.2 | -0.33 |
Chronic Fatigue Syndrome | 1.8 | 4 | -1.22 |
Chronic Kidney Disease | 0.6 | 0.6 | 0 |
Chronic Lyme | 0.8 | 0.8 | |
Chronic Obstructive Pulmonary Disease (COPD) | 0.5 | 2 | -3 |
Chronic Urticaria (Hives) | 0.2 | 0.6 | -2 |
Coagulation / Micro clot triggering bacteria | 1.4 | 0.8 | 0.75 |
Colorectal Cancer | 1.9 | 4.5 | -1.37 |
Constipation | 1.2 | 1.1 | 0.09 |
Coronary artery disease | 0.6 | 0.8 | -0.33 |
COVID-19 | 6.8 | 6.1 | 0.11 |
Crohn's Disease | 5.1 | 6.7 | -0.31 |
cystic fibrosis | 1.2 | 0.3 | 3 |
deep vein thrombosis | 1.4 | 0.5 | 1.8 |
Depression | 6.6 | 6.8 | -0.03 |
Dermatomyositis | 0.6 | 0.6 | |
Eczema | 2.3 | 1.4 | 0.64 |
Endometriosis | 2 | 1.2 | 0.67 |
Eosinophilic Esophagitis | 0.6 | 0.6 | |
Epilepsy | 1.8 | 3.8 | -1.11 |
erectile dysfunction | 0.5 | 0.3 | 0.67 |
Fibromyalgia | 1.4 | 1.3 | 0.08 |
Functional constipation / chronic idiopathic constipation | 2.5 | 3.8 | -0.52 |
gallstone disease (gsd) | 1.5 | 1.7 | -0.13 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.2 | -1.2 | |
Generalized anxiety disorder | 1.4 | 1.4 | |
Glioblastoma | 0.5 | 0.3 | 0.67 |
Gout | 0.3 | -0.3 | |
Graves' disease | 1.2 | 1.4 | -0.17 |
Halitosis | 0.5 | 1.8 | -2.6 |
Hashimoto's thyroiditis | 1.2 | 1.8 | -0.5 |
Hidradenitis Suppurativa | 0.6 | 0.6 | |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.3 | 1.8 | -5 |
hyperglycemia | 1.2 | 1.2 | |
Hyperlipidemia (High Blood Fats) | 0.9 | 0.6 | 0.5 |
hypersomnia | 0.3 | 0.3 | |
hypertension (High Blood Pressure | 2 | 4.5 | -1.25 |
Hypothyroidism | 0.8 | 0.3 | 1.67 |
Hypoxia | 0.6 | -0.6 | |
IgA nephropathy (IgAN) | 3.3 | 0.2 | 15.5 |
Inflammatory Bowel Disease | 4.2 | 2.6 | 0.62 |
Insomnia | 0.9 | 1.4 | -0.56 |
Intelligence | 0.8 | 0.9 | -0.13 |
Intracranial aneurysms | 0.3 | 1.4 | -3.67 |
Irritable Bowel Syndrome | 4.9 | 4.4 | 0.11 |
Liver Cirrhosis | 5.3 | 5.3 | 0 |
Long COVID | 7.8 | 6.2 | 0.26 |
Low bone mineral density | 0.8 | 0.9 | -0.13 |
Lung Cancer | 0.5 | 0.4 | 0.25 |
ME/CFS with IBS | 1.2 | 1.2 | 0 |
ME/CFS without IBS | 1.2 | 1.2 | |
Menopause | 0.2 | 0.8 | -3 |
Metabolic Syndrome | 5.5 | 7.8 | -0.42 |
Mood Disorders | 6.9 | 8.5 | -0.23 |
multiple chemical sensitivity [MCS] | 1.2 | -1.2 | |
Multiple Sclerosis | 1.5 | 2.8 | -0.87 |
Multiple system atrophy (MSA) | 1.1 | 0.2 | 4.5 |
myasthenia gravis | 0.3 | 0.3 | 0 |
neuropsychiatric disorders (PANDAS, PANS) | 0.6 | -0.6 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.2 | 0.8 | 3 |
NonCeliac Gluten Sensitivity | 0.6 | 0.6 | |
Obesity | 5.3 | 4 | 0.32 |
obsessive-compulsive disorder | 2.4 | 3.8 | -0.58 |
Osteoarthritis | 0.5 | 0.8 | -0.6 |
Osteoporosis | 1.5 | 2.1 | -0.4 |
pancreatic cancer | 0.3 | 0.3 | |
Parkinson's Disease | 2.1 | 3.3 | -0.57 |
Polycystic ovary syndrome | 2.9 | 1.2 | 1.42 |
Postural orthostatic tachycardia syndrome | 0.8 | 0.8 | |
Premenstrual dysphoric disorder | 0.6 | 0.6 | 0 |
primary biliary cholangitis | 0.2 | 0.6 | -2 |
Psoriasis | 2.1 | 2.8 | -0.33 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 4.4 | 3.3 | 0.33 |
Rosacea | 0.6 | 1.4 | -1.33 |
Schizophrenia | 2.3 | 3.5 | -0.52 |
scoliosis | 0.7 | 0.7 | |
sensorineural hearing loss | 0.3 | -0.3 | |
Sjögren syndrome | 2.5 | 2.2 | 0.14 |
Sleep Apnea | 2 | 2 | 0 |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.7 | 0.9 | -0.29 |
Stress / posttraumatic stress disorder | 1.6 | 1.5 | 0.07 |
Systemic Lupus Erythematosus | 2.8 | 2.3 | 0.22 |
Tic Disorder | 1.4 | 0.3 | 3.67 |
Tourette syndrome | 0.6 | 0.3 | 1 |
Type 1 Diabetes | 1 | 2.4 | -1.4 |
Type 2 Diabetes | 5 | 5.2 | -0.04 |
Ulcerative colitis | 4.3 | 2.5 | 0.72 |
Unhealthy Ageing | 1.1 | 1.4 | -0.27 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.